Niva Bupa Health Insurance Company Ltd.

Industry:

Insurance

Issue Details

  • Open Date

    07 Nov 2024
  • Close Date

    11 Nov 2024
  • Size (in Crs.)

    1279.14

  • Size (Shares)

    -
  • Listing On

    BSE, NSE

Issue Terms

  • Price Range

    -4
  • Lot Size

    200

  • Type

    Book building

  • Face Value

    10

  • Market Lot

    1

Objective of the Issue

1. Augmentation of its capital base to strengthen solvency levels and2. General corporate purposes

Description

Our purpose is to “give every Indian the confidence to access the best healthcare”. We aim to achieve this purpose through our health insurance products and services that enable customers to navigate their healthcare journey, by providing them access to a holistic health ecosystem. According to the Redseer Report, we are one of India’s largest and fastest growing SAHI based on overall health GDPI of ?54,944.28 million in Fiscal 2024. From Fiscal 2022 to Fiscal 2024, our overall GWP grew at a CAGR of 41.27% and...  Show More

Address

C-98, First Floor , Lajpat Nagar , Part 1, South Delhi

New Delhi

110024

State

Delhi

Phone No.

0124-6354900

Email

investor@nivabupa.com

Website

www.nivabupa.com

Promoter Holding

Promoters:

Bupa Investments Overseas Ltd., Bupa Singapore Holdings Pte Ltd., Fettle Tone LLP

Total Share Capital

1531008578

Offered to Public

172857143

% Promoter's Holding (Pre-Issue)  

88.98

% Promoter's Holding (Post-Issue)  

73.37

Shares on offer

Total Share Offer

1531008578

Of above offred to public

172857143

Post Issue shares

NA

Post Issue Promoters

73.37

Lead Managers to the Issue:

Axis Capital Ltd., HDFC Bank Ltd., ICICI Securities Ltd, Kotak Mahindra Capital Co Ltd, Morgan Stanley India Co Pvt Ltd, Motilal Oswal Investment Advisors Pvt Ltd

Registrar Details

Registrar Name:

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Address

Karvy Selenium Tower B, Plot 31-32 , Gachibowli,Financial District , Nanakramguda , Hyderabad

500032

Phone No.

040 - 67162222/18003094001

Email

einward.ris@kfintech.com

Website

www.kfintech.com

Fax

-

Prudent Corporate Advisory Services Ltd.
"Prudent House", Panjrapole Cross Road,
Nr. Polytechnic, Ambawadi,
Ahmedabad - 380 015, Gujarat, India.
For Queries:
kyc@fundzbazar.com
1800 419 5051 (Toll Free)
Compliance Officer:
Mrs. Rima Patel
compliancemf@prudentcorporate.com
(079) 40209600
Social Media

Prudent Corporate Advisory Services Ltd.(PCAS): Member of NSE & BSE – SEBI Registration No as stock broker: INZ000293634. Member ID : - NSE : 90209, BSE : 6733, CDSL – IN-DP- 477-2020 (DP ID: 12090600), Research Analyst - INH000018115, CIN - L91120GJ2003PLC042458.

Registered Address: Prudent House, Panjrapole Cross Road, Nr. Polytechnic, Ambawadi, Ahmedabad - 380015, Gujarat, India.

For any complaints pertaining to securities / broking please write a mail to ig@prudentcorporate.com

Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI

Investor Alert:
  1. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  2. Prevent Unauthorized transactions in your Trading / Demat account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange / CDSL on your mobile/email at the end of the day / same day.......... Issued in the interest of investors.
  3. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor's account.
  4. Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.
  5. Filing complaints on SCORES – Easy & quick
    • a. Register on SCORES portal b. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. c. Benefits: i. Effective communication. ii.Speedy redressal of the grievances.
  6. SEBI COMPLAINTS REDRESS SYSTEM Link :- https://scores.gov.in/scores/Welcome.html
  • Attention Investor:
  • 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the NSE's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 & BSE’s notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors

Company does not offer any scheme for any assured returns. In case, any such scheme offered by any of employee or other Authorized Person of the company, the same should not be accepted and no investment in such scheme to be made. In case of any such scheme offered by any person, kindly contact compliance team of the company on (+91) (79) 40209600. In case any investment made in such scheme, company will not be responsible for any claims or grievances for any loss on account of relying on the said scheme. 

Advertisement Disclosure - Non-Broking Products/Services e.g. Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc "These are not Exchange traded product and the Member is just acting as distributor and all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.”